Understanding the interplay among CCDC80, LDHA and LDHB could provide insights into the metabolic reprogramming of cancer cells and identify novel targets for therapeutic intervention aimed at restoring normal metabolic processes and enhancing anti-tumor immunity. The gene discussed is LDHB; the disease is cancer.